Newark, DE, United States of America

Jing Pan

This inventor holds 16 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Anp Technologies, Inc., Fulgent Genetics, Inc., Fulgent Therapeutics, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Pan. Retrieved from https://idiyas.com/inventor/jing-pan-xyh92e2t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovator Jing Pan: Advancements in Drug Delivery Through Innovative Polymers

Introduction

Jing Pan, an accomplished inventor based in Newark, DE, has made significant strides in the field of drug delivery technology. With a portfolio of 14 patents, his innovations focus on improving the solubility, stability, and efficacy of pharmaceutical compounds through innovative polymer aggregates.

Latest Patents

Among Jing Pan's latest patents are two groundbreaking innovations. The first, titled "Hydrophobic molecule-induced branched polymer aggregates and their use," describes a method of modifying symmetrically and asymmetrically branched homopolymers with functional groups. This modification enables the formation of aggregates with poorly water-soluble pharmaceutically active agents. The resulting aggregates enhance drug solubility, stability, delivery, and efficacy, distinguishing them from aggregates formed solely by the homopolymer or the active agents alone.

The second patent, "Nanoparticles containing a taxane and their use," focuses specifically on the interaction of branched homopolymers with taxanes, such as paclitaxel. Similar to his previous work, the aggregates formed in this patent improve the delivery of poorly soluble drugs, further emphasizing Jing Pan's commitment to enhancing pharmaceutical applications through innovative polymer science.

Career Highlights

Jing Pan has held significant roles in prominent organizations, including Anp Technologies, Inc. and Fulgent Therapeutics, Inc. His work in these companies has allowed him to harness his expertise in polymer chemistry to drive advancements in drug formulation and delivery systems.

Collaborations

Collaborating with fellow researchers, including Ray Yin and Dujie Qin, Jing Pan has fostered an environment of innovation and creativity. Together, they have contributed to pioneering solutions that bridge the gap between chemistry and pharmacology.

Conclusion

Jing Pan's inventive spirit and dedication to enhancing drug delivery mechanisms through polymer technology render him an influential figure in the field. As he continues to develop new solutions that address the challenges of drug solubility and delivery, his contributions promise to yield significant benefits for the pharmaceutical industry and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…